Pain in the substance abuse population

Current Therapy in Pain

Volumn , Issue , 2009, Pages 392-395

  Passik, Steven D ^a   Kirsh, Kenneth L ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883971020     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4836-7.00052-3     Document Type: Chapter

References (16)

1. Kirsh KL, Passik SD Patients with a history of substance abuse. Opioid Therapy in the 21st Century 2008, 155-161. Oxford University Press, New York. H.S. Smith (Ed.).
2. Passik SD, Hays L, Eisner N, Kirsh KL Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation. J Pain Palliat Care Pharmacother 2006, 20:5-13.
3. Hancock CM OxyContin use and abuse. Clin J Oncol Nurs 2002, 6:109.
4. Office of Applied Studies of the Substance Abuse and Mental Health Services Administration. Results from the 2005 National Survey on Drug Use and Health: National Findings. Department of Health and Human Services. Publication No. SMA 06-4194. Available at: (Accessed July 10, 2008). http://www.oas.samhsa.gov/NSDUH/2k5NSDUH/2k5results.htm.
5. Hays L, Kirsh KL, Passik SD Seeking drug treatment for oxycontin abuse: a chart review of consecutive admissions to a substance abuse treatment facility in the bluegrass region of Kentucky. J Natl Compr Cancer Netw 2003, 1:423-428.
6. Lamberg L New guidelines on managing chronic pain in older persons. JAMA 1998, 280:311-312.
7. Verhaak PFM, Kerssens JJ, Dekker J, et al. Prevalence of chronic benign pain disorder among adults: a review of the literature. Pain 1998, 77:231-239.
8. Passik SD, Weinreb HJ Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids. Adv Ther 2000, 17:70-80.
9. Rinaldi RC, Steindler EM, Wilford BB, Goodwin D Clarification and standardization of substance abuse terminology. JAMA 1988, 259:555.
10. Weissman DE, Haddox JD Opioid pseudoaddiction-an iatrogenic syndrome. Pain 1989, 36:363-366.
11. Hay JL, Passik SD The cancer patient with borderline personality disorder: suggestions for symptom-focused management in the medical setting. Psychooncology 2000, 9:91-100.
12. Brookoff D Abuse potential of various opioid medications. J Gen Intern Med 1993, 8:688-690.
13. Drug Abuse Warning Network. Emergency department trends from the drug abuse warning network, preliminary estimates January-June 2002. Drug Abuse Warning Network Series. National Clearinghouse for Alcohol and Drug Information, Rockville, MD. Available at: (Accessed July, 2008). http://www.samhsa.gov/oas/dawn/TrndED/2001/Text/TrndEDtxt.PDF.
14. Savage SR, Kirsh KL, Passik SD Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract 2008, 4:4-25. Available at: http://www.drugabuse.gov/PDF/ascp/vol4no2/Challenges.pdf.
15. Engel GL The clinical application of the biopsychosocial model. Am J Psychiatry 1980, 137:535-544.
16. Passik SD, Schreiber J, Kirsh KL, Portenoy RK A chart review of the ordering and documentation of urine toxicology screens in a cancer center: do they influence patient management?. J Pain Symptom Manage 2000, 19:40-44.